Microbix Biosystems Inc.
MBXBF
$0.19
-$0.01-6.41%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.13M | -3.09M | -1.64M | -237.90K | 1.13M |
| Total Depreciation and Amortization | 1.27M | 1.24M | 1.25M | 1.12M | 1.11M |
| Total Amortization of Deferred Charges | 50.30K | 50.30K | 25.30K | 102.10K | 102.10K |
| Total Other Non-Cash Items | 873.30K | 837.60K | 818.60K | 805.40K | 684.40K |
| Change in Net Operating Assets | -1.49M | -1.55M | -526.20K | -1.36M | -181.60K |
| Cash from Operations | -3.42M | -2.50M | -70.50K | 430.10K | 2.85M |
| Capital Expenditure | -535.00K | -545.80K | -568.70K | -625.00K | -1.02M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -197.80K |
| Cash from Investing | -535.00K | -545.80K | -568.70K | -625.00K | -1.22M |
| Total Debt Issued | 359.30K | 359.30K | 359.30K | -- | -- |
| Total Debt Repaid | -439.10K | -2.22M | -2.23M | -2.23M | -2.48M |
| Issuance of Common Stock | 0.00 | 2.74M | 2.82M | 2.82M | 2.82M |
| Repurchase of Common Stock | -836.30K | -1.39M | -1.73M | -1.84M | -1.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -658.90K | -371.60K | -558.40K | -898.10K | -1.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -4.61M | -3.42M | -1.20M | -1.09M | 622.10K |